Senior Scientific Director, Neurodegenerative Diseases

Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology? Within Danaher the work our diagnostic businesses do saves lives—and we’re all united by a shared commitment to innovate for tangible impact. You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life.

We’re accelerating the development of cutting-edge diagnostics to solve some of the world’s most pressing health challenges. Across our diagnostics operating companies we are driving innovation through partnerships with top academic institutions and leading players in biopharma and translational research. We’re bringing the best minds together to accelerate innovation and unlock the full potential of the latest scientific advances. Together, we’re expanding access to precision diagnostics for millions of people worldwide - and we’re using our unmatched global scale and proven playbook to make it happen, from hospital labs to mobile clinics.

By helping providers, patients, and families get faster, more precise diagnostic results, we’re improving treatment options and saving lives. Learn about the Danaher Business System which makes everything possible.

• Shape scientific strategy for the neurodegenerative disease franchise, translating it into integrated evidence plans that guide portfolio, technology roadmap, and product development decisions.
• Lead flagship research programs end‑to‑end—including academic partnerships and a multimodal patient registry—owning scientific design, execution, milestones, and readouts.
• Drive external scientific insight by designing and chairing advisory boards and leadership forums to inform internal strategy and decision‑making.
• Build and represent expert networks across academia, consortia, and societies while partnering with diagnostics, biopharma, and academic collaborators on research, validation studies, and publications.
• Evaluate external innovation and partnership opportunities in neurodegeneration, shaping investment recommendations with the CSO and embedding DBS standard work, metrics, and AI‑enabled practices across the scientific agenda.

• MD, MD/PhD or PhD in medicine, neuroscience or a related discipline, with extensive post-qualification experience in diagnostics, biopharma, biotechnology or academic medicine, including significant time in senior scientific, clinical or translational leadership roles engaging external expert networks and scientific advisory boards at global scale. A medical degree with clinical experience in neurology, psychiatry, geriatrics or a related specialty is strongly preferred.
• Deep expertise in biomarker development for neurologic disease, spanning discovery through clinical deployment, with working command of assay performance characteristics, pre-analytical variables and the distinction between analytical validation, clinical validation and clinical utility.
• Demonstrated experience leading clinical strategy and evidence generation programs in neurodegenerative disease or an adjacent specialty area, with personal accountability for study design, execution against committed timelines, readout and publication.
• Working knowledge of in vitro diagnostic product development, regulatory pathways such as United States Food and Drug Administration clearance and the European Union In Vitro Diagnostic Regulation, and the evidence requirements supporting diagnostic claims.
• Scientific writing and communication strength sufficient to author and critically review protocols, study…